Nitric Oxide Patent Expiration

1. Genosyl patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6758214 VERO BIOTECH INC Simple nitric oxide generator for ambulatory and/or bedside inhaled no treatment
Feb, 2022

(2 years ago)

US9956373 VERO BIOTECH INC Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Aug, 2025

(1 year, 1 month from now)

US11554241 VERO BIOTECH INC Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Aug, 2025

(1 year, 1 month from now)

US8609028 VERO BIOTECH INC Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Aug, 2025

(1 year, 1 month from now)

US9522249 VERO BIOTECH INC Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Aug, 2025

(1 year, 1 month from now)

US8821801 VERO BIOTECH INC Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Aug, 2025

(1 year, 1 month from now)

US11291793 VERO BIOTECH INC Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Aug, 2025

(1 year, 1 month from now)

US8226916 VERO BIOTECH INC Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Aug, 2025

(1 year, 1 month from now)

US10124142 VERO BIOTECH INC Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Aug, 2025

(1 year, 1 month from now)

US11383059 VERO BIOTECH INC Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Aug, 2025

(1 year, 1 month from now)

US10814092 VERO BIOTECH INC Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Oct, 2025

(1 year, 3 months from now)

US8057742 VERO BIOTECH INC Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Jan, 2026

(1 year, 6 months from now)

US7618594 VERO BIOTECH INC Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Oct, 2026

(2 years from now)

US7947227 VERO BIOTECH INC Kit for the conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Oct, 2026

(2 years from now)

US7560076 VERO BIOTECH INC Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Apr, 2027

(2 years from now)

US9701538 VERO BIOTECH INC Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Jan, 2029

(4 years from now)

US9604028 VERO BIOTECH INC Systems and devices for generating nitric oxide
Aug, 2029

(5 years from now)

US8944049 VERO BIOTECH INC Systems and devices for generating nitric oxide
Aug, 2029

(5 years from now)

US10926054 VERO BIOTECH INC Systems and devices for generating nitric oxide
Aug, 2029

(5 years from now)

US11511252 VERO BIOTECH INC Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Sep, 2029

(5 years from now)

US11103669 VERO BIOTECH INC Nitric oxide therapies
Jun, 2030

(5 years from now)

US8607785 VERO BIOTECH INC Systems and devices for generating nitric oxide
Jul, 2030

(6 years from now)

US10737051 VERO BIOTECH INC Nitrogen dioxide storage device
Oct, 2035

(11 years from now)

US10213572 VERO BIOTECH INC Nitrogen dioxide storage cassette
Feb, 2036

(11 years from now)

US11672938 VERO BIOTECH INC Start-up protocols for nitric oxide delivery device
Jul, 2040

(16 years from now)




Market Authorisation Date: 20 December, 2019

Treatment: A method of delivering nitric oxide to a patient; A method for delivering nitric oxide to a patient with pulmonary hypertension or hypoxia

Dosage: GAS

More Information on Dosage

GENOSYL family patents

Family Patents

2. Inomax patent expiration

INOMAX IPR and PTAB Proceedings
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5485827 MALLINCKRODT HOSP Methods and devices for treating plumonary vasoconstriction and asthma
Jan, 2013

(11 years ago)

US5873359 MALLINCKRODT HOSP Methods and devices for treating pulmonary vasoconstriction and asthma
Jan, 2013

(11 years ago)

US5485827

(Pediatric)

MALLINCKRODT HOSP Methods and devices for treating plumonary vasoconstriction and asthma
Jul, 2013

(10 years ago)

US5873359

(Pediatric)

MALLINCKRODT HOSP Methods and devices for treating pulmonary vasoconstriction and asthma
Jul, 2013

(10 years ago)

US5558083 MALLINCKRODT HOSP Nitric oxide delivery system
Nov, 2013

(10 years ago)

US5558083

(Pediatric)

MALLINCKRODT HOSP Nitric oxide delivery system
May, 2014

(10 years ago)

US5752504 MALLINCKRODT HOSP System for monitoring therapy during calibration
Dec, 2016

(7 years ago)

US5732693 MALLINCKRODT HOSP Pause control of nitric oxide therapy
Dec, 2016

(7 years ago)

US6125846 MALLINCKRODT HOSP Purge system for nitric oxide administration apparatus
May, 2017

(7 years ago)

US5752504

(Pediatric)

MALLINCKRODT HOSP System for monitoring therapy during calibration
Jun, 2017

(7 years ago)

US5732693

(Pediatric)

MALLINCKRODT HOSP Pause control of nitric oxide therapy
Jun, 2017

(7 years ago)

US6125846

(Pediatric)

MALLINCKRODT HOSP Purge system for nitric oxide administration apparatus
Nov, 2017

(6 years ago)

US8846112 MALLINCKRODT HOSP Methods of distributing a pharmaceutical product comprising nitric oxide gas for inhalation
Jun, 2029

(4 years from now)

US8293284 MALLINCKRODT HOSP Methods of reducing the risk of occurrence of pulmonary edema in term or near-term neonates in need of treatment with inhaled nitric oxide
Jun, 2029

(4 years from now)

US8282966 MALLINCKRODT HOSP Methods of reducing the risk of occurrence of pulmonary edema in children in need of treatment with inhaled nitric oxide
Jun, 2029

(4 years from now)

US8431163 MALLINCKRODT HOSP Methods of reducing the risk of occurrence of pulmonary edema associated with inhalation of nitric oxide gas
Jun, 2029

(4 years from now)

US8795741 MALLINCKRODT HOSP Methods for treating patients who are candidates for inhaled nitric oxide treatment
Jun, 2029

(4 years from now)

US8846112

(Pediatric)

MALLINCKRODT HOSP Methods of distributing a pharmaceutical product comprising nitric oxide gas for inhalation
Dec, 2029

(5 years from now)

US8282966

(Pediatric)

MALLINCKRODT HOSP Methods of reducing the risk of occurrence of pulmonary edema in children in need of treatment with inhaled nitric oxide
Dec, 2029

(5 years from now)

US8293284

(Pediatric)

MALLINCKRODT HOSP Methods of reducing the risk of occurrence of pulmonary edema in term or near-term neonates in need of treatment with inhaled nitric oxide
Dec, 2029

(5 years from now)

US8431163

(Pediatric)

MALLINCKRODT HOSP Methods of reducing the risk of occurrence of pulmonary edema associated with inhalation of nitric oxide gas
Dec, 2029

(5 years from now)

US8795741

(Pediatric)

MALLINCKRODT HOSP Methods for treating patients who are candidates for inhaled nitric oxide treatment
Dec, 2029

(5 years from now)

US8573209 MALLINCKRODT HOSP Gas delivery device and system
Jan, 2031

(6 years from now)

US8573210 MALLINCKRODT HOSP Nitric oxide delivery device
Jan, 2031

(6 years from now)

US8776795 MALLINCKRODT HOSP Gas delivery device and system
Jan, 2031

(6 years from now)

US9408993 MALLINCKRODT HOSP Nitric oxide delivery device
Jan, 2031

(6 years from now)

US8291904 MALLINCKRODT HOSP Gas delivery device and system
Jan, 2031

(6 years from now)

US8776794 MALLINCKRODT HOSP Nitric oxide delivery device
Jan, 2031

(6 years from now)

US9295802 MALLINCKRODT HOSP Gas delivery device and system
Jan, 2031

(6 years from now)

US9265911 MALLINCKRODT HOSP Gas delivery device and system
Jan, 2031

(6 years from now)

US8776794

(Pediatric)

MALLINCKRODT HOSP Nitric oxide delivery device
Jul, 2031

(6 years from now)

US8776795

(Pediatric)

MALLINCKRODT HOSP Gas delivery device and system
Jul, 2031

(6 years from now)

US8573210

(Pediatric)

MALLINCKRODT HOSP Nitric oxide delivery device
Jul, 2031

(6 years from now)

US8573209

(Pediatric)

MALLINCKRODT HOSP Gas delivery device and system
Jul, 2031

(6 years from now)

US9408993

(Pediatric)

MALLINCKRODT HOSP Nitric oxide delivery device
Jul, 2031

(6 years from now)

US9265911

(Pediatric)

MALLINCKRODT HOSP Gas delivery device and system
Jul, 2031

(6 years from now)

US8291904

(Pediatric)

MALLINCKRODT HOSP Gas delivery device and system
Jul, 2031

(6 years from now)

US9295802

(Pediatric)

MALLINCKRODT HOSP Gas delivery device and system
Jul, 2031

(6 years from now)

US9279794 MALLINCKRODT HOSP Systems and methods for compensating long term sensitivity drift of electrochemical gas sensors exposed to nitric oxide
Feb, 2034

(9 years from now)

US9279794

(Pediatric)

MALLINCKRODT HOSP Systems and methods for compensating long term sensitivity drift of electrochemical gas sensors exposed to nitric oxide
Aug, 2034

(10 years from now)

US9770570 MALLINCKRODT HOSP Apparatus and method for monitoring nitric oxide delivery
May, 2036

(11 years from now)

US9770570

(Pediatric)

MALLINCKRODT HOSP Apparatus and method for monitoring nitric oxide delivery
Nov, 2036

(12 years from now)




Drug Exclusivity Drug Exclusivity Expiration
M(M-132) Dec 21, 2013
Pediatric Exclusivity(PED) Jun 21, 2014
M(M-167) Oct 09, 2018

Market Authorisation Date: 23 December, 1999

Treatment: Prevention or treatment of reversible vasoconstriction by the inhalation of nitric oxide with an oxygen containing gas; A method of providing a predetermined concentration of nitric oxide to a patient...

Dosage: GAS

How can I launch a generic of INOMAX before it's drug patent expiration?
More Information on Dosage

INOMAX family patents

Family Patents